Neoadjuvant ICI Without Chemotherapy Demonstrates Potential Efficacy in Patients with Early-Stage TNBC By Ogkologos - November 21, 2024 928 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the BELLINI study Source RELATED ARTICLESMORE FROM AUTHOR Mezigdomide-Carfilzomib-Dexamethasone Prolongs PFS Compared with Carfilzomib-Dexamethasone at First Relapse in Patients with Relapsed Or Refractory Multiple Myeloma FDA Approves Durvalumab in Combination with BCG for High-Risk Non-Muscle Invasive Bladder Cancer Systemic Aging Associated with a Higher Risk of Early-Onset Solid Cancers MOST POPULAR A Peripheral Immune Signature of Responsiveness to PD-1 Blockade in cHL August 25, 2020 Cancer Patient Dresses Up To Cheer Others In Chemo & The... March 18, 2019 FDA Grants Accelerated Approval to fam-Trastuzumab Deruxtecan-nxki for Unresectable or Metastatic... April 12, 2024 Surgical Technique Helps Keep Breast Cancer Patients from Going Under the... September 26, 2019 Load more HOT NEWS 3D-Printed Surgical Guides Are Helping Surgeons Save More Breast Tissue While... Rationale Explained for Granting EMA Authorisation for Extended Use of Nivolumab... New on NCI’s Websites for June 2022 FDA Grants Traditional Approval to Selpercatinib for RET Fusion-positive Thyroid Cancer
